p57kip2 (PT0280R) rabbit mAb

  • Catalog No.:YM7182
  • Applications:IHC; WB;; ELISA
  • Reactivity:Human;
    • Target:
    • p57
    • Fields:
    • >>Cell cycle
    • Gene Name:
    • CDKN1C
    • Protein Name:
    • Beckwith Wiedemann syndrome;BWCR;BWS;CDKI;CDKN 1C;CDKN1C;CDN1C_HUMAN;Cyclin dependent kinase inhibitor 1C;Cyclin dependent kinase inhibitor p57;Cyclin-dependent kinase inhibitor 1C;Cyclin-dependent ki
    • Human Swiss Prot No:
    • P49918
    • Mouse Swiss Prot No:
    • P49919
    • Immunogen:
    • Synthesized peptide derived from human p57kip2 AA range:200-316
    • Specificity:
    • This antibody detects endogenous levels of p57
    • Formulation:
    • PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA
    • Source:
    • Monoclonal, Rabbit IgG1, Kappa
    • Dilution:
    • IHC 1:100-500, WB 1:500-1000, ELISA 1:5000-20000
    • Purification:
    • Recombinant Expression and Affinity purified
    • Storage Stability:
    • -15°C to -25°C/1 year(Do not lower than -25°C)
    • Other Name:
    • Beckwith Wiedemann syndrome;BWCR;BWS;CDKI;CDKN 1C;CDKN1C;CDN1C_HUMAN;Cyclin dependent kinase inhibitor 1C;Cyclin dependent kinase inhibitor p57;Cyclin-dependent kinase inhibitor 1C;Cyclin-dependent kinase inhibitor p57;KIP 2;KIP2;p57;p57 Kip 2;p57KIP2;WBS
    • Molecular Weight(Da):
    • 35kD
    • Background:
    • This gene is imprinted, with preferential expression of the maternal allele. The encoded protein is a tight-binding, strong inhibitor of several G1 cyclin/Cdk complexes and a negative regulator of cell proliferation. Mutations in this gene are implicated in sporadic cancers and Beckwith-Wiedemann syndorome, suggesting that this gene is a tumor suppressor candidate. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Oct 2010],
    • Function:
    • disease:Defects in CDKN1C are a cause of Beckwith-Wiedemann syndrome (BWS) [MIM:130650]. BWS is a genetically heterogeneous disorder characterized by anterior abdominal wall defects including exomphalos (omphalocele), pre- and postnatal overgrowth, and macroglossia. Additional less frequent complications include specific developmental defects and a predisposition to embryonal tumors.,disease:Defects in CDKN1C are involved in tumor formation.,function:Potent tight-binding inhibitor of several G1 cyclin/CDK complexes (cyclin E-CDK2, cyclin D2-CDK4, and cyclin A-CDK2) and, to lesser extent, of the mitotic cyclin B-CDC2. Negative regulator of cell proliferation. May play a role in maintenance of the non-proliferative state throughout life.,similarity:Belongs to the CDI family.,tissue specificity:Expressed in the heart, brain, lung, skeletal muscle, kidney, pancreas and testis. High levels ar
    • Subcellular Location:
    • Nuclear
    • Expression:
    • Placenta/ Kindey